Neuberger Berman Group LLC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 145 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Neuberger Berman Group LLC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$16,179,869
+40.2%
3,825,610
+2.1%
0.02%
+50.0%
Q2 2023$11,539,269
+125.9%
3,747,939
+1.8%
0.01%
+100.0%
Q1 2023$5,109,006
-26.4%
3,682,627
+5.5%
0.01%
-28.6%
Q4 2022$6,944,413
-1.7%
3,489,655
+0.0%
0.01%0.0%
Q3 2022$7,063,000
-31.4%
3,487,919
+8.1%
0.01%
-30.0%
Q2 2022$10,292,000
-22.9%
3,227,892
+0.9%
0.01%
-9.1%
Q1 2022$13,344,000
-14.4%
3,198,368
-2.1%
0.01%
-8.3%
Q4 2021$15,585,000
-10.8%
3,268,548
-1.3%
0.01%
-20.0%
Q3 2021$17,473,000
+1.9%
3,312,174
-1.6%
0.02%0.0%
Q2 2021$17,145,000
-25.3%
3,366,081
-2.0%
0.02%
-31.8%
Q1 2021$22,959,000
+39.3%
3,434,266
-5.1%
0.02%
+29.4%
Q4 2020$16,481,000
+15.4%
3,619,822
-1.8%
0.02%0.0%
Q3 2020$14,281,000
-19.7%
3,685,477
-1.4%
0.02%
-22.7%
Q2 2020$17,793,000
+33.8%
3,739,184
-2.4%
0.02%
+10.0%
Q1 2020$13,303,000
-21.5%
3,830,086
+8.9%
0.02%0.0%
Q4 2019$16,941,000
+63.5%
3,517,916
-1.4%
0.02%
+53.8%
Q3 2019$10,362,000
-44.1%
3,567,199
+38.0%
0.01%
-40.9%
Q2 2019$18,529,000
-23.5%
2,584,650
+51.1%
0.02%
-26.7%
Q1 2019$24,227,000
+6.5%
1,709,999
+1.7%
0.03%
-6.2%
Q4 2018$22,755,000
-40.4%
1,681,252
-2.2%
0.03%
-25.6%
Q3 2018$38,156,000
+30.9%
1,719,798
-3.2%
0.04%
+34.4%
Q2 2018$29,142,0001,775,8930.03%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$83,503,0007.34%
Eversept Partners, LP 2,656,208$10,306,0872.29%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$62,908,0001.13%
Prosight Management, LP 512,659$1,989,0000.95%
THB ASSET MANAGEMENT 833,104$3,232,0000.90%
GLOBEFLEX CAPITAL L P 251,696$977,0000.26%
XTX MARKETS LLC 10,243$40,0000.19%
HUSSMAN STRATEGIC ADVISORS, INC. 102,000$396,0000.10%
PA Capital LLC 33,874$132,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 60,900$236,0000.07%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders